Thunderstorm asthma: an overview of mechanisms and management strategies. (2nd October 2020)

• Record Type: Journal Article
• Authors: Thien, Francis; Davies, Janet M.; Hew, Mark; Douglass, Jo A.; O'Hehir, Robyn E.
• Is Part Of: Expert review of clinical immunology. Volume 16:Number 10(2020)
• Page Start: 1005
• Page End: 1017
• Publication Date: 2020-10-02
• Subjects: Aeroallergens -- allergic asthma -- allergic rhinitis -- asthma mortality -- immunotherapy; Clinical immunology -- Periodicals; 616.079
• DOI: 10.1080/1744666X.2021.1826310
• Languages: English
• ISSNs: 1744-666X

Abstract

ABSTRACT: Introduction: Epidemic thunderstorm asthma (ETSA) is due to a complex interaction of environmental and individual susceptibility factors, with outbreaks reported globally over the last four decades. Australia has been particularly susceptible with nearly half of episodes reported internationally, culminating in the catastrophic Melbourne 2016 event. Areas covered: Reported ETSA episodes are reviewed for common environmental and meteorological risk factors. Allergen aerobiology interaction with thunderstorm activity and rapid weather condition changes is examined. Assessment of the clinical and immunological data highlights risk factors for ETSA presentation, hospital admission, and intensive care admission. Risk factors associated with ETSA deaths are evaluated. Public health strategies, as well as pharmacological and immunological management approaches to reduce individual susceptibility and prevent ETSA are discussed. Expert opinion: Improved understanding of the specific meteorological factors predisposing to the greatest risk of ETSA to improve forecasting is required. Better monitoring of aeroallergen levels in areas of greatest geographic risk, with further research into allergen aerobiology underpinning mechanisms of allergen exposure is needed. The role of climate change in increasing the risk of ETSA outbreaks requires further research. Public awareness and education are required to reduce exposure, and to improve uptake of pharmacological and immunological risk reduction and preventive strategies.